1)  Ranolazine sustained release tablets
					
	
					
				
				
	
					
				雷诺嗪缓释片
				1.
					Conclusion:Ranolazine sustained release tablets have marked sustained release characters.
					
					
						
						
					
						方法:采用双周期自身交叉设计,分别单剂量给予犬雷诺嗪缓释片和普通片,用HPLC法测定血浆中的雷诺嗪浓度,用DAS 2。
					
					3)  Cetirizine and Pseudoephedrine sustained release tablets
					
	
					
				
				
	
					
				西嗪伪麻缓释片
				1.
					OBJECTIVE:To study the pharmacokinetic profiles of Pseudoephedrine in healthy volunteers after multiple dosing of Cetirizine and Pseudoephedrine sustained release tablets.
						
						目的:研究健康受试者多次口服国产西嗪伪麻缓释片后伪麻黄碱的药动学特点。
					
					4)  ranolazine
					
	
					
				
				
	
					
				雷诺嗪
				1.
					Optimization of Preparation Technology and In Vitro Dissolution Rate of Ranolazine Sustained Release Tablets;
						
						雷诺嗪缓释片的制备工艺筛选及其体外溶出度考察
					2.
					Determination of residual solvents in ranolazine by headspace gas chromatography;
					
					
						
						
					
						顶空气相色谱法测定雷诺嗪中5种有机溶剂残留量
					3.
					Long-term toxicity of ranolazine in rats;
					
					
						
						
					
						雷诺嗪对大鼠的长期毒性试验
					
					5)  gastric floating sustained-release tablets of Triperygium wilfordii
					
	
					
				
				
	
					
				雷公藤胃漂浮缓释片
				1.
					Preparation of gastric floating sustained-release tablets of Triperygium wilfordii and its quality evaluation
						
						雷公藤胃漂浮缓释片的制备和质量评价
					
					6)  Ranolazine hydrochloride
					
	
					
				
				
	
					
				盐酸雷诺嗪
				1.
					Determination of ranolazine hydrochloride in rat urine and study on its gender-related metabolism by RP-HPLC;
						
						RP-HPLC法研究不同性别的大鼠尿液中盐酸雷诺嗪及其代谢物的差异
					2.
					Chemiluminescence determination of ranolazine hydrochloride
					
					
						
						
					
						化学发光法测定盐酸雷诺嗪含量
					补充资料:雷诺嗪
		分子式:C24H33N3O4
分子量:暂无
CAS号:95635-55-5
性质:暂无
制备方法:暂无
用途:抗心绞痛新药。
		
		分子量:暂无
CAS号:95635-55-5
性质:暂无
制备方法:暂无
用途:抗心绞痛新药。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
	参考词条